Systemic lupus erythematosus and Coombs positive haemolytic anaemia

Summary:

Coombs positive haemolytic anaemia is found among people with Systemic lupus erythematosus, especially for people who are female, 60+ old.

The study analyzes which people have Coombs positive haemolytic anaemia with Systemic lupus erythematosus. It is created by eHealthMe based on reports of 24 people who have Systemic lupus erythematosus from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Systemic lupus erythematosus?

Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue) is found to be associated with 1,089 drugs and 1,642 conditions by eHealthMe. Check the latest studies of Systemic lupus erythematosus.

What is Coombs positive haemolytic anaemia?

Coombs positive haemolytic anaemia is found to be associated with 63 drugs and 175 conditions by eHealthMe. Check the latest studies of Coombs positive haemolytic anaemia.



On Jul, 19, 2026

24 people who have Systemic Lupus Erythematosus and Coombs Positive Haemolytic Anaemia are studied.

Would you have Coombs positive haemolytic anaemia when you have Systemic lupus erythematosus?

Gender of people who have Systemic Lupus Erythematosus and experienced Coombs Positive Haemolytic Anaemia *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Systemic Lupus Erythematosus and experienced Coombs Positive Haemolytic Anaemia *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 25 %
  • 30-39: 25 %
  • 40-49: 0.0 %
  • 50-59: 25 %
  • 60+: 25 %

Common co-existing conditions for these people *:

  1. White Blood Cell Count Decreased: 21 people, 87.50%
  2. Lymphopenia (an abnormally low level of lymphocytes in the blood): 18 people, 75.00%

Common drugs taken by these people *:

  1. Benlysta: 22 people, 91.67%
  2. Pentacarinat: 21 people, 87.50%
  3. Fluvastatin: 21 people, 87.50%
  4. Eliquis: 20 people, 83.33%
  5. Mcp: 17 people, 70.83%
  6. Morphine: 9 people, 37.50%
  7. Valsartan: 1 person, 4.17%
  8. Rituxan: 1 person, 4.17%
  9. Prednisolone: 1 person, 4.17%
  10. Plaquenil: 1 person, 4.17%

Common symptoms for these people *:

  1. Lymphopenia (an abnormally low level of lymphocytes in the blood): 22 people, 91.67%
  2. Depression: 22 people, 91.67%
  3. Antiphospholipid Syndrome (disorder that manifests clinically as recurrent venous or arterial thrombosis and/or fetal loss): 21 people, 87.50%
  4. Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs): 21 people, 87.50%
  5. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 21 people, 87.50%
  6. Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 21 people, 87.50%
  7. Urinary Tract Infection: 21 people, 87.50%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 21 people, 87.50%
  9. Leukopenia (less number of white blood cells in blood): 21 people, 87.50%
  10. Gastritis Haemorrhagic (inflammation of stomach with bleeding): 21 people, 87.50%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Coombs positive haemolytic anaemia?

- Check whether Coombs positive haemolytic anaemia is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Coombs positive haemolytic anaemia:

All the conditions that are associated with Coombs positive haemolytic anaemia:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Coombs positive haemolytic anaemia and Systemic lupus erythematosus, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: